GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aspen Pharmacare Holdings Ltd (OTCPK:APNHY) » Definitions » Median PS Value
中文

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Median PS Value

: $13.95 (As of Today)
View and export this data going back to 2009. Start your Free Trial

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Aspen Pharmacare Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $5.143. Aspen Pharmacare Holdings's 10-Year median PS Ratio is 2.7124. Therefore, the Median PS Value for today is $13.95.

As of today (2024-04-24), Aspen Pharmacare Holdings's share price is $11.17. Aspen Pharmacare Holdings's Median PS Value is $13.95. Therefore, Aspen Pharmacare Holdings's Price to Median PS Value for today is 0.80.

The historical rank and industry rank for Aspen Pharmacare Holdings's Median PS Value or its related term are showing as below:

APNHY' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.34   Med: 0.75   Max: 1.22
Current: 0.8

During the past 13 years, the highest Price to Median PS Value of Aspen Pharmacare Holdings was 1.22. The lowest was 0.34. And the median was 0.75.

APNHY's Price-to-Median-PS-Value is ranked worse than
51.4% of 500 companies
in the Drug Manufacturers industry
Industry Median: 0.79 vs APNHY: 0.80

Aspen Pharmacare Holdings Median PS Value Historical Data

The historical data trend for Aspen Pharmacare Holdings's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspen Pharmacare Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.85 15.91 20.98 18.97 13.88

Aspen Pharmacare Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 18.97 - 13.88 -

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Aspen Pharmacare Holdings's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aspen Pharmacare Holdings Price-to-Median-PS-Value Distribution

For the Drug Manufacturers industry and Healthcare sector, Aspen Pharmacare Holdings's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Aspen Pharmacare Holdings's Price-to-Median-PS-Value falls into.



Aspen Pharmacare Holdings Median PS Value Calculation

Aspen Pharmacare Holdings's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=5.143*2.7124
=13.95

10-Year Median PS Ratio is 2.7124.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aspen Pharmacare Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $5.143.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aspen Pharmacare Holdings  (OTCPK:APNHY) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Aspen Pharmacare Holdings's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=11.17/13.95
=0.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aspen Pharmacare Holdings Median PS Value Related Terms

Thank you for viewing the detailed overview of Aspen Pharmacare Holdings's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Business Description

Traded in Other Exchanges
Address
Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Headlines

From GuruFocus

Value Idea Contest: Aspen Pharmacare

By Matthew Sipos Matthew Sipos 03-17-2019